Scholars@Duke

Editor' summary: A paradigm shift in castration-resistant prostate cancer management.

Publication ,  Journal Article
De Nunzio, C; Amstrong, AJ; Van Oort, I; Dorff, T
Published in: Prostate Cancer Prostatic Dis
April 2022
Published version (DOI) Link to item

Duke Scholars

Andrew John Armstrong
Author Andrew John Armstrong Medicine, Medical Oncology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Prostate Cancer Prostatic Dis

DOI

10.1038/s41391-022-00574-x

EISSN

1476-5608

Publication Date

April 2022

Volume

25

Issue

4

Start / End Page

601 / 603

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Receptors, Androgen
  • Prostatic Neoplasms, Castration-Resistant
  • Male
  • Humans
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Nunzio, C., Amstrong, A. J., Van Oort, I., & Dorff, T. (2022). Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis, 25(4), 601–603. https://doi.org/10.1038/s41391-022-00574-x
De Nunzio, Cosimo, Andrew J. Amstrong, Inge Van Oort, and Tanya Dorff. “Editor' summary: A paradigm shift in castration-resistant prostate cancer management.” Prostate Cancer Prostatic Dis 25, no. 4 (April 2022): 601–3. https://doi.org/10.1038/s41391-022-00574-x.
De Nunzio C, Amstrong AJ, Van Oort I, Dorff T. Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):601–3.
De Nunzio, Cosimo, et al. “Editor' summary: A paradigm shift in castration-resistant prostate cancer management.” Prostate Cancer Prostatic Dis, vol. 25, no. 4, Apr. 2022, pp. 601–03. Pubmed, doi:10.1038/s41391-022-00574-x.
De Nunzio C, Amstrong AJ, Van Oort I, Dorff T. Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):601–603.

Published In

Prostate Cancer Prostatic Dis

DOI

10.1038/s41391-022-00574-x

EISSN

1476-5608

Publication Date

April 2022

Volume

25

Issue

4

Start / End Page

601 / 603

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Receptors, Androgen
  • Prostatic Neoplasms, Castration-Resistant
  • Male
  • Humans
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis